Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo (Q45253902)

11 December 2017

Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo (English)

1 reference

11 December 2017

1 reference

1 reference

Maria Brown

1

1 reference

11 December 2017

Michael McGuinness

2

1 reference

11 December 2017

Terry Wright

3

1 reference

11 December 2017

Xiaoping Ren

4

1 reference

11 December 2017

Yang Wang

5

1 reference

11 December 2017

Gregory P Boivin

6

1 reference

11 December 2017

Harvey Hahn

7

1 reference

11 December 2017

Arthur M Feldman

8

1 reference

11 December 2017

W Keith Jones

9

1 reference

11 December 2017

language of work or name

1 reference

4 February 2005

1 reference

American Journal of Physiology Heart and Circulatory Physiology

11 December 2017

1 reference

11 December 2017

289

1 reference

11 December 2017

H466-76

1 reference

11 December 2017

1

1 reference

Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha.

11 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

NF-kappaB activation is required for the development of cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Inhibition of I kappaB-alpha phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Nuclear factor kappa-B and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00170.2004

10.1152/AJPHEART.00170.2004

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference